Acetyl-l-carnitine Cognitive Performance Meta-analysis: What the Evidence Says

Quick Answer

Acetyl-l-carnitine Cognitive Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 preclinical study, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Acetyl-l-carnitine long-term neurotrophic and analgesic activity is supported by evidence from both preclinical models and clinical studies in peripheral neuropathies. [Fornasari Diego Maria Michele (2026); evidence level 4]
• It is also found in several foods, with red meats, such as beef and lamb, being its richest sources. [Fornasari Diego Maria Michele (2026); evidence level 4]
• Mendelian randomization (MR) presents a causal inference methodology to examine the effect of modifiable exposure on a disease by leveraging genetic variants to provide evidence of robust associations. [Luan Sisi (2025); evidence level 4]
• S1 Our study adopted the TSMR design, an approach that leverages genetic variants as instrumental variables and utilizes summary statistics from two independent samples, which could minimize confounding and reverse causation and provide more robust evidence for causality. [Luan Sisi (2025); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For acetyl-l-carnitine cognitive performance meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Fornasari Diego Maria Michele (2026). Acetyl- l -Carnitine in the Treatment of Peripheral Neuropathies: A Narrative Review. DOI: 10.1007/s40122-026-00826-x. PMCID: PMC13172195. PMID: 41824218. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/ This article is licens.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13172195/
• Luan Sisi (2025). The Effect of Acylcarnitines on Cognitive Function: A Two‐Sample Mendelian Randomization Study. DOI: 10.1002/brb3.70646. PMCID: PMC12224038. PMID: 40607651. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12224038/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.